Introduced March 30, 2026 by Yassamin Ansari · Last progress March 30, 2026
The bill aims to improve diagnosis, research, clinician training, and public awareness for PMDD—potentially improving care and equity—but does so through open-ended, multi-year authorizations that raise taxpayer costs and depend on future appropriations and careful implementation to avoid uneven benefits.
Women and people with PMDD will have better diagnosis and timelier care because the bill expands clinician education, awareness campaigns, and guidance to reduce misdiagnosis.
Women with PMDD will benefit from expanded federal research that could produce clearer diagnostic criteria and more effective treatments over time.
Medical, nursing, and pharmacy students and practicing clinicians will gain more training (residency/fellowship/CME), increasing workforce capacity to treat mid-life women’s health and PMDD.
Taxpayers could face increased federal spending because the bill authorizes multi-year funding with unspecified "such sums as necessary," raising budgetary cost uncertainty.
Women and patients may not see promised research, education, or access improvements if Congress does not appropriate funds despite the bill's authorizations.
Scientists, researchers, and other HHS priorities could be negatively affected if NIH/HHS reallocate limited staff or funds to PMDD efforts, delaying other projects.
Based on analysis of 6 sections of legislative text.
Expands federal research, awareness campaigns, provider training grants, data collection, and reporting to improve diagnosis and treatment of PMDD and authorizes funding.
Creates a federal effort to expand research, education, clinical training, public awareness, and data collection about Premenstrual Dysphoric Disorder (PMDD). It directs HHS (through NIH and HRSA) to fund and coordinate studies, clinical trials, continuing education for providers, grant programs for training, and a public awareness campaign, and requires a progress report to Congress. The measure authorizes “such sums as necessary” for specified fiscal years to carry out these activities.